Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

NCT03940703

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Compassionate Care Research Group Inc - Edinger Medical Group, Inc. Fountain Valley, California, United States
  • Memorial Care Long Beach, California, United States
  • Ventura County Hematology Oncology Specialists Oxnard, California, United States
View all 179 locations
View Trial Details
Active, Not Recruiting

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

NCT04130516

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
View Trial Details
Active, Not Recruiting

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

NCT05450692

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Chandler, Arizona, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
View all 191 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

NCT05048797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Anchorage, Alaska, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

NCT04886804

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Precision NextGen Oncology Beverly Hills, California, United States
  • City of Hope-Duarte-56419 Duarte, California, United States
  • City of Hope - Seacliff Huntington Beach, California, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06711900

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital. Capital Medical University Beijing, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • Peking University Third Hospital Beijing, China
View all 81 locations
View Trial Details

Related conditions